<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The use of implantable cardioverter defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) in patients with <z:hpo ids='HP_0001664'>torsade de pointes</z:hpo> (TdP) and <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> in the presence of acquired <z:hpo ids='HP_0001657'>long QT syndrome</z:hpo> (aLQTS) is under debate, partly due to the fact that aLQTS is potentially reversible and currently no long-term follow-up data are available </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to evaluate the long-term follow-up of patients with acquired <z:hpo ids='HP_0001657'>long QT syndrome</z:hpo> (aLQTS) who had received an implantable cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) for secondary prevention of sudden <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> (SCA) </plain></SENT>
<SENT sid="2" pm="."><plain>METHOD AND RESULTS: Over a 10 year period, 43 patients with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> after survived <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> (SCA) due to an aLQTS were included [female n= 27 (63%); mean age 61 ± 16 years] </plain></SENT>
<SENT sid="3" pm="."><plain>There was no clinical evidence for congenital LQTS (Schwartz score 1.25 ± 0.8) </plain></SENT>
<SENT sid="4" pm="."><plain>Structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> was present in 29 patients (47%; ischaemic n= 13; <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> n= 9; mean EF 41%± 12) </plain></SENT>
<SENT sid="5" pm="."><plain>The most common proarrhythmic trigger happened to be antiarrhythmic drugs (n= 34; 79%) </plain></SENT>
<SENT sid="6" pm="."><plain>Other triggers included contrast agent (n= 1), <z:chebi fb="6" ids="5613">haloperidol</z:chebi> (n= 2), severe hypokalaemia (n= 2), <z:e sem="disease" ids="C0013146" disease_type="Mental or Behavioral Dysfunction" abbrv="">drug abuse</z:e>/alcohol (n= 2), and mere severe <z:hpo ids='HP_0001662'>bradycardia</z:hpo> (n= 2) </plain></SENT>
<SENT sid="7" pm="."><plain>Under trigger QTc interval measured 536 ± 58 vs. 438 ± 33 ms without trigger (P&lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>During a mean follow-up of 84 ± 55 months, appropriate shocks occurred in 19 patients (44%); inappropriate shocks in 13 patients (30%; only inappropriate n= 3) </plain></SENT>
<SENT sid="9" pm="."><plain>Appropriate shocks were almost as common in patients without as in those with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> (35 vs. 48%; P= 0.32) </plain></SENT>
<SENT sid="10" pm="."><plain>None of the patients were re-exposed to the initial trigger during the follow-up period </plain></SENT>
<SENT sid="11" pm="."><plain>Beta-blocker medication did not prevent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks (12 of 19 vs. 11 of 24 on medication) </plain></SENT>
<SENT sid="12" pm="."><plain>ConcluSION: Appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks are a common finding in patients with aLQTS and SCA irrespective of the underlying cause or structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Thus, even in the presence of relevant acquired proarrhythmia <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> may be beneficial </plain></SENT>
</text></document>